£1.5M
The funding round was led by Supernode Global with participation from Andy Davis.
A
Atomico
Venture CapitalAtomico manages funds supporting early-stage and growth-stage European technology companies.
Recent investments
£11.6M
LabGenius raises £11.6m in a Series A extension led by Atomico to scale its drug discovery platform.
The funding round was led by Atomico with participation from Lux Capital, Obvious Ventures, Kindred Capital and Inovia Capital.
"To add a fund of Atomico’s calibre and reputation to our investor base is a huge win for LabGenius. Atomico’s operational experience is second to none and they are the perfect partner to help us scale a global company from Europe. In addition, the confidence that Lux, Obvious, Kindred and Inovia have demonstrated in doubling down in this round reflects the tremendous technical progress that the team has made over the past 12 months."
£30.7M
The Series B round was led by Lakestar with participation from LocalGlobe, Atomico, GMG Ventures, and Octopus, and will fund platform development and headcount growth.
"Human reality is incredibly complex, and while technology has made progress in healthcare and pharmaceuticals, we’re still no closer to truly understanding the decisions that we make. Our behaviour is captured online and in the artificial reality of social media, but the near 80 percent of our lives that happens in the offline world, remains untapped,"
£35.0M
The Series C round was led by Augmentum Fintech, SBI Group and mojo.capital to support continued company growth.
"At Habito, we’re on a mission to make mortgages easier for anyone who wants to own a home in the UK. For too long, the odds have been stacked against customers who still have to put up with poor service, uncompetitive products and punishing loyalty penalties. The tide is turning on traditional home financing and we’re here to usher in a new future of home financing that combines the very best of human expertise with the efficacy of technology and reduces cost, stress, time and friction for all."
Augmentum Fintech + 6 others
£43.9M
The financing round was led by Atomico with participation from several returning and new investors.
"The size of this Series B financing, especially this quickly after our Series A round last year, is an endorsement of the value of our platform and the pace at which we have developed. It allows us to scale our impact with the launch of our Rare Treatment Accelerator programme and to progress into clinical trials."